
|Videos|May 5, 2017
Which Rx-to-OTC Switches Could Be on the Horizon?
Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate professor at the Ernesto Mario School of Pharmacy, Rutgers University, discusses potential Rx-to-OTC switches.
Advertisement
Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate professor at the Ernesto Mario School of Pharmacy, Rutgers University, discusses potential Rx-to-OTC switches.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
New CKD Outcome Set Tells Pharmacists What to Measure
4
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
5





































































































